Quanhe Yang1, Xin Tong2, Mary G George2, Anping Chang2, Robert K Merritt2. 1. From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA. qay0@cdc.gov. 2. From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND AND OBJECTIVES: Findings of association between coronavirus disease 2019 (COVID-19) and stroke remain inconsistent, ranging from significant association to absence of association to less than expected ischemic stroke among hospitalized patients with COVID-19. The current study examined the association between COVID-19 and risk of acute ischemic stroke (AIS). METHODS: We included 37,379 Medicare fee-for-service (FFS) beneficiaries aged ≥65 years diagnosed with COVID-19 from April 1, 2020, through February 28, 2021, and AIS hospitalization from January 1, 2019, through February 28, 2021. We used a self-controlled case series design to examine the association between COVID-19 and AIS and estimated the incidence rate ratios (IRRs) by comparing incidence of AIS in risk periods (0-3, 4-7, 8-14, 15-28 days after diagnosis of COVID-19) vs control periods. RESULTS: Among 37,379 Medicare FFS beneficiaries with COVID-19 and AIS, the median age at diagnosis of COVID-19 was 80.4 (interquartile range 73.5-87.1) years and 56.7% were women. When AIS at day of exposure (day = 0) was included in the risk periods, IRRs at 0-3, 4-7, 8-14, and 15-28 days following COVID-19 diagnosis were 10.3 (95% confidence interval 9.86-10.8), 1.61 (1.44-1.80), 1.44 (1.32-1.57), and 1.09 (1.02-1.18); when AIS at day 0 was excluded in the risk periods, the corresponding IRRs were 1.77 (1.57-2.01) (day 1-3), 1.60 (1.43-1.79), 1.43 (1.31-1.56), and 1.09 (1.01-1.17), respectively. The association appeared to be stronger among younger beneficiaries and among beneficiaries without prior history of stroke but largely consistent across sex and race/ethnicities. DISCUSSION: Risk of AIS among Medicare FFS beneficiaries was 10 times (day 0 cases in the risk period) as high during the first 3 days after diagnosis of COVID-19 as during the control period and the risk associated with COVID-19 appeared to be stronger among those aged 65-74 years and those without prior history of stroke. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of AIS in the first 3 days after diagnosis in Medicare FFS beneficiaries ≥65 years of age.
BACKGROUND AND OBJECTIVES: Findings of association between coronavirus disease 2019 (COVID-19) and stroke remain inconsistent, ranging from significant association to absence of association to less than expected ischemic stroke among hospitalized patients with COVID-19. The current study examined the association between COVID-19 and risk of acute ischemic stroke (AIS). METHODS: We included 37,379 Medicare fee-for-service (FFS) beneficiaries aged ≥65 years diagnosed with COVID-19 from April 1, 2020, through February 28, 2021, and AIS hospitalization from January 1, 2019, through February 28, 2021. We used a self-controlled case series design to examine the association between COVID-19 and AIS and estimated the incidence rate ratios (IRRs) by comparing incidence of AIS in risk periods (0-3, 4-7, 8-14, 15-28 days after diagnosis of COVID-19) vs control periods. RESULTS: Among 37,379 Medicare FFS beneficiaries with COVID-19 and AIS, the median age at diagnosis of COVID-19 was 80.4 (interquartile range 73.5-87.1) years and 56.7% were women. When AIS at day of exposure (day = 0) was included in the risk periods, IRRs at 0-3, 4-7, 8-14, and 15-28 days following COVID-19 diagnosis were 10.3 (95% confidence interval 9.86-10.8), 1.61 (1.44-1.80), 1.44 (1.32-1.57), and 1.09 (1.02-1.18); when AIS at day 0 was excluded in the risk periods, the corresponding IRRs were 1.77 (1.57-2.01) (day 1-3), 1.60 (1.43-1.79), 1.43 (1.31-1.56), and 1.09 (1.01-1.17), respectively. The association appeared to be stronger among younger beneficiaries and among beneficiaries without prior history of stroke but largely consistent across sex and race/ethnicities. DISCUSSION: Risk of AIS among Medicare FFS beneficiaries was 10 times (day 0 cases in the risk period) as high during the first 3 days after diagnosis of COVID-19 as during the control period and the risk associated with COVID-19 appeared to be stronger among those aged 65-74 years and those without prior history of stroke. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of AIS in the first 3 days after diagnosis in Medicare FFS beneficiaries ≥65 years of age.
Authors: Tiffany E Chang; Xin Tong; Mary G George; Sallyann M Coleman King; Xiaoping Yin; Suzanne O'Brien; Ghada Ibrahim; Alice Liskay; Jennifer L Wiltz Journal: Stroke Date: 2019-06-18 Impact factor: 7.914
Authors: Shadi Yaghi; Koto Ishida; Jose Torres; Brian Mac Grory; Eytan Raz; Kelley Humbert; Nils Henninger; Tushar Trivedi; Kaitlyn Lillemoe; Shazia Alam; Matthew Sanger; Sun Kim; Erica Scher; Seena Dehkharghani; Michael Wachs; Omar Tanweer; Frank Volpicelli; Brian Bosworth; Aaron Lord; Jennifer Frontera Journal: Stroke Date: 2020-05-20 Impact factor: 7.914
Authors: Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi Journal: N Engl J Med Date: 2020-04-28 Impact factor: 91.245
Authors: George Ntaios; Patrik Michel; Georgios Georgiopoulos; Yutao Guo; Wencheng Li; Jing Xiong; Patricia Calleja; Fernando Ostos; Guillermo González-Ortega; Blanca Fuentes; María Alonso de Leciñana; Exuperio Díez-Tejedor; Sebastian García-Madrona; Jaime Masjuan; Alicia DeFelipe; Guillaume Turc; Bruno Gonçalves; Valerie Domigo; Gheorghe-Andrei Dan; Roxana Vezeteu; Hanne Christensen; Louisa Marguerite Christensen; Per Meden; Lejla Hajdarevic; Angela Rodriguez-Lopez; Fernando Díaz-Otero; Andrés García-Pastor; Antonio Gil-Nuñez; Errikos Maslias; Davide Strambo; David J Werring; Arvind Chandratheva; Laura Benjamin; Robert Simister; Richard Perry; Rahma Beyrouti; Pascal Jabbour; Ahmad Sweid; Stavropoula Tjoumakaris; Elisa Cuadrado-Godia; Ana Rodríguez Campello; Jaume Roquer; Tiago Moreira; Michael V Mazya; Fabio Bandini; Karl Matz; Helle K Iversen; Alejandra González-Duarte; Cristina Tiu; Julia Ferrari; Milan R Vosko; Helmut J F Salzer; Bernd Lamprecht; Martin W Dünser; Carlo W Cereda; Ángel Basilio Corredor Quintero; Eleni Korompoki; Eduardo Soriano-Navarro; Luis Enrique Soto-Ramírez; Paulo F Castañeda-Méndez; Daniela Bay-Sansores; Antonio Arauz; Vanessa Cano-Nigenda; Espen Saxhaug Kristoffersen; Marjaana Tiainen; Daniel Strbian; Jukka Putaala; Gregory Y H Lip Journal: Stroke Date: 2020-07-09 Impact factor: 7.914
Authors: Erin R Kulick; Michelle Canning; Neal S Parikh; Mitchell S V Elkind; Amelia K Boehme Journal: J Am Heart Assoc Date: 2020-10-08 Impact factor: 5.501